THUMBNAIL_00000000_Prof Andrew Sindone_1_2_Square

Prof Andrew Sindone

Cardiologist; Director of the Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital; Head, Department of Cardiology, Ryde Hospital
A practicing Cardiologist with private practice in Ryde and Westmead, the Director of the Heart Failure Unit and Department of Cardiac Rehabilitation at Concord Hospital, and Head of Department of Cardiology at Ryde Hospital. He has a long history of cardiovascular research having presented over 100 research papers both nationally and internationally. He has been principal investigator in more than 35 international multi-centre research trials and is an advisor to the NSW Ministry of Health, as well as being co-author of the Australian Guidelines for the Management of Chronic Heart Failure.

More from this expert

Videos iconVideos

In this Product Explainer, Prof Andrew Sindone, cardiologist at Concord and Ryde Hospitals in Sydney, explains the role of rivaroxaban in anticoagulation and when and to whom it can be prescribed (5 mins).

Podcasts iconPodcasts

Detecting atrial fibrillation and commencing anticoagulation- latest evidence of the incidence and prevalence of both AF and stroke, why the vast majority of AF patients can safely be put on preventive therapy to optimise their chances of a stroke-free future.

Podcasts iconPodcasts

How health professionals must auscultate for murmurs in all patients over 65 years, and refer for an echo or to a cardiologist, How the symptoms of chest pain, syncope and dyspnoea appear late, and the prognosis is very poor with 50% mortality in two years, TAVI being a safe, effective, and highly cost-effective treatment for patients with aortic stenosis, and how we should be referring our patients earlier for consideration of this procedure and its current availability for only privately insured patients, unfortunately

In this Product Explainer, Prof Andrew Sindone, cardiologist at Concord and Ryde Hospitals in Sydney, explains the role of rivaroxaban in anticoagulation and when and to whom it can be prescribed (5 mins).

Videos iconVideos

Insight and understanding into how to identify and assess complications of DOACs, and, importantly, how adverse effects of DOACs can be best managed.

Podcasts iconPodcasts

In this Product Explainer, Prof Andrew Sindone, Cardiologist and Director of the Heart Failure Unit at the Concord Hospital explains the cardiovascular advantages of a high-dose quadrivalent influenza vaccine for active immunisation for the prevention of influenza disease indicated for use in persons 60 years of age and older (5 mins).

Videos iconVideos

A practical framework for treating heart failure.

Podcasts iconPodcasts

The impact of aortic stenosis, even when NOT severe, is underestimated- Transcatheter Aortic Valve Implantation (TAVI) has revolutionised treatment and recent changes to reimbursement mean that it is even more available.

Podcasts iconPodcasts

Detecting atrial fibrillation and commencing anticoagulation- latest evidence of the incidence and prevalence of both AF and stroke, why the vast majority of AF patients can safely be put on preventive therapy to optimise their chances of a stroke-free future.

Podcasts iconPodcasts

How health professionals must auscultate for murmurs in all patients over 65 years, and refer for an echo or to a cardiologist, How the symptoms of chest pain, syncope and dyspnoea appear late, and the prognosis is very poor with 50% mortality in two years, TAVI being a safe, effective, and highly cost-effective treatment for patients with aortic stenosis, and how we should be referring our patients earlier for consideration of this procedure and its current availability for only privately insured patients, unfortunately

Podcasts iconPodcasts

Catching the flu significantly increases the risk of myocardial infarction, stroke, hospitalisation for heart failure and increased CV morality

Podcasts iconPodcasts